Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication August 14, 2020
- Accepted for publication October 21, 2020
- Published online July 6, 2021.
Copyright & Usage
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- 1Department of Nuclear Medicine, University Hospitals of Bordeaux, TRAIL, University of Bordeaux, Bordeaux, France;
- 2Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, Michigan;
- 3Nuclear Medicine and Molecular Imaging, ICANS, University Hospitals of Strasbourg, University of Strasbourg, IPHC, Strasbourg, France;
- 4Endocrine Surgery, La Timone Hospital, Aix-Marseille University, Marseille, France; and
- 5Nuclear Medicine, La Timone Hospital, CERIMED, Aix-Marseille University, Marseille, France
- For correspondence or reprints, contact Elif Hindié (elif.hindie{at}chu-bordeaux.fr).
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
- Article
- Visual Abstract
- Abstract
- IMAGING IS RECOMMENDED BEFORE FIRST PARATHYROID SURGERY IRRESPECTIVE OF SURGICAL APPROACH
- ADVANTAGES AND DISADVANTAGES OF TARGETED SURGERY: IMPLICATIONS REGARDING CHOICE OF IMAGING
- WHY IS 99mTc-SESTAMIBI/123I SUBTRACTION IMAGING BETTER OPTION THAN DUAL-PHASE SESTAMIBI SCANNING FOR GUIDING TARGETED SURGERY?
- SECOND-LINE IMAGING STRATEGY WHEN SCINTIGRAPHY AND NECK ULTRASOUND RESULTS ARE NEGATIVE, DISCORDANT, OR INCONCLUSIVE
- IS IT TOO EARLY TO PROPOSE 18F-FLUOROCHOLINE PET/CT AS FIRST-LINE IMAGING?
- LOCALIZATION PROCEDURES BEFORE REPEAT SURGERY FOR PERSISTENT OR RECURRENT HYPERPARATHYROIDISM
- CONCLUSION
- DISCLOSURE
- ACKNOWLEDGMENT
- REFERENCES
- Figures & Data
- Info & Metrics